Essential thrombocythemia (NORD)
77,672views
00:00 / 00:00
Videos
Notes
Essential thrombocythemia (NORD)
Information for patients and families
Osmosis
Using an inhaler: Information for patients and families
Managing diabetes during the holidays: Information for patients and families
The flu vaccine: Information for patients and families
Bike helmet safety: Information for patients and families
The Primary School
Toxic stress: Information for patients and families (The Primary School)
ADHD: Information for patients and families (The Primary School)
Asthma: Information for patients and families (The Primary School)
Childhood nutrition and obesity: Information for patients and families (The Primary School)
Childhood oral health: Information for patients and families (The Primary School)
Food allergies and EpiPens: Information for patients and families (The Primary School)
Glut1 Deficiency Foundation
Glut1 deficiency syndrome (Glut1 Deficiency Foundation)
The National Organization for Rare Disorders (NORD)
Narcolepsy (NORD)
Adrenoleukodystrophy (NORD)
Zellweger spectrum disorders (NORD)
Glycogen storage disease type II (NORD)
Metachromatic leukodystrophy (NORD)
Gaucher disease (NORD)
Niemann-Pick disease types A and B (NORD)
Fabry disease (NORD)
Tay-Sachs disease (NORD)
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Phenylketonuria (NORD)
Cystinuria (NORD)
Aromatic L-amino acid decarboxylase deficiency (NORD)
Cerebrotendinous xanthomatosis (NORD)
Classical homocystinuria (NORD)
Autoimmune polyglandular syndrome type 1 (NORD)
Thyroid eye disease (NORD)
Opsoclonus myoclonus syndrome (NORD)
Thyroid eye disease (NORD)
Short bowel syndrome (NORD)
Bile synthesis disorders (NORD)
Eosinophilic esophagitis (NORD)
Cyclic vomiting syndrome (NORD)
Polycythemia vera (NORD)
Essential thrombocythemia (NORD)
Myelofibrosis (NORD)
Warm autoimmune hemolytic anemia and cold agglutinin (NORD)
Sickle cell disease (NORD)
Waldenstrom macroglobulinemia (NORD)
Post-transplant lymphoproliferative disorders (NORD)
Cytomegalovirus infection after transplant (NORD)
Mycobacterium avium complex (NORD)
Congenital cytomegalovirus (NORD)
Opsoclonus myoclonus syndrome (NORD)
Spinocerebellar ataxia (NORD)
Early infantile epileptic encephalopathy (NORD)
IgA nephropathy (NORD)
Focal segmental glomerulosclerosis (NORD)
Alagille syndrome (NORD)
NGLY1 deficiency (NORD)
Recurrent pericarditis (NORD)
Assessments
Essential thrombocythemia (NORD)
Flashcards
0 / 11 complete
USMLE® Step 1 questions
0 / 2 complete
Flashcards
Essential thrombocythemia (NORD)
of complete
Questions
USMLE® Step 1 style questions USMLE
of complete
| Laboratory value | Result |
| Hemoglobin | 9.5 g/dL |
| Hematocrit | 28.5% |
| Leukocytes | 2,700/mm3 |
| Platelets | 100,000/mm3 |
Biopsy of the bone marrow biopsy shows increased fibrosis and reduced cell count. Polymerase chain reaction testing reveals a mutation in a gene encoding for a non-receptor tyrosine kinase. Which of the following diseases is also caused by an identical mutation?
Memory Anchors and Partner Content
External References
First Aid
2022
2021
2020
2019
2018
2017
2016
Bleeding
essential thrombocythemia p. 441
Essential thrombocythemia p. 441
Thrombosis
essential thrombocythemia p. 441
External Links
Transcript
Content Reviewers
Rishi Desai, MD, MPHContributors
Stefan Stoisavljevic, MD
Alex Aranda
Essential thrombocythemia is a slowly progressive disease where the bone marrow produces too many platelets.
In rare cases, essential thrombocythemia can develop into myelofibrosis and acute leukemia.
Now, the vast majority of bone marrow is made of hematopoietic cells which are the early progenitor cells that can differentiate into other cell types.
In the case of platelets, progenitor cells differentiate into megakaryocytes, which are responsible for creating platelets.
In essential thrombocythemia there’s a genetic mutation that occurs in the Janus Kinase 2 gene, also called JAK2, or somewhere along this pathway of cell signalling.
Normally, the liver and kidneys produce a a tiny hormone called thrombopoietin which binds to hematopoietic cell receptors.
When it binds, those cells activate the JAK2 gene which makes them divide and mature into megakaryocytes and platelets.
Cells can also develop mutations in the thrombopoietin receptor, MPL, or in the chaperone protein, Calreticulin or CalR.
Now, when there’s a genetic mutation in CalR, the signalling pathway remains active all the time, and that means that platelets keep getting produced even in the absence of thrombopoietin.
Although there are lots of platelets that are made, many of them end up being misshapen - they’re large and irregularly shaped.
Now, all of these excess platelets end up causing an increased risk of blood clots in the deep veins of the legs, lungs, and even sites where clots don’t usually form, like the abdomen.
As a result, there’s an increased risk of stroke, heart attack, and miscarriage.
Now, if the number of platelets is extremely high, over 1.5 million, then there’s an increased risk of bleeding.
Copyright © 2023 Elsevier, except certain content provided by third parties
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.
